| Net Cash Provided by (Used in) Operating Activities |
-249K |
USD |
-122% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
202M |
USD |
|
Q1 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-201M |
USD |
|
Q1 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
5.67M |
shares |
+10.9% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-249K |
USD |
-112% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.08M |
USD |
-37.9% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |